Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway.
Glyscend Address
1812 Ashland Avenue Baltimore, MD United States
Glyscend Email
Past Companies
Glyscend TherapeuticsSenior Scientist
Glyscend IncorporatedResearch Scientist
Northeastern UniversityGraduate Research Assistant | Project Management